NO151895C - Fremgangsmaate for fremstilling av pyrido-indolderivater - Google Patents

Fremgangsmaate for fremstilling av pyrido-indolderivater

Info

Publication number
NO151895C
NO151895C NO794317A NO794317A NO151895C NO 151895 C NO151895 C NO 151895C NO 794317 A NO794317 A NO 794317A NO 794317 A NO794317 A NO 794317A NO 151895 C NO151895 C NO 151895C
Authority
NO
Norway
Prior art keywords
indold
pyrido
derivatives
procedure
preparation
Prior art date
Application number
NO794317A
Other languages
English (en)
Norwegian (no)
Other versions
NO794317L (no
NO151895B (no
Inventor
Willard Mckowan Welch Jr
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO794317L publication Critical patent/NO794317L/no
Publication of NO151895B publication Critical patent/NO151895B/no
Publication of NO151895C publication Critical patent/NO151895C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42Separation; Purification; Stabilisation; Use of additives
    • C07C51/487Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
NO794317A 1979-01-23 1979-12-28 Fremgangsmaate for fremstilling av pyrido-indolderivater NO151895C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/005,698 US4224329A (en) 1979-01-23 1979-01-23 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles

Publications (3)

Publication Number Publication Date
NO794317L NO794317L (no) 1980-07-24
NO151895B NO151895B (no) 1985-03-18
NO151895C true NO151895C (no) 1985-06-26

Family

ID=21717248

Family Applications (2)

Application Number Title Priority Date Filing Date
NO794317A NO151895C (no) 1979-01-23 1979-12-28 Fremgangsmaate for fremstilling av pyrido-indolderivater
NO843041A NO843041L (no) 1979-01-23 1984-07-27 Nye 5-(fluorfenyl)-2-hydroksytetra-hydrofuraner

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO843041A NO843041L (no) 1979-01-23 1984-07-27 Nye 5-(fluorfenyl)-2-hydroksytetra-hydrofuraner

Country Status (34)

Country Link
US (1) US4224329A (ko)
JP (4) JPS55100386A (ko)
KR (1) KR830001932A (ko)
AR (1) AR231291A1 (ko)
AT (1) AT376674B (ko)
AU (1) AU521986B2 (ko)
BE (1) BE881283A (ko)
CA (1) CA1144168A (ko)
CH (2) CH651040A5 (ko)
CS (4) CS221809B2 (ko)
DD (2) DD149071A5 (ko)
DE (1) DE3002367A1 (ko)
DK (1) DK25580A (ko)
EG (1) EG14767A (ko)
FI (1) FI800179A (ko)
FR (3) FR2447379A1 (ko)
GB (1) GB2041925B (ko)
GR (1) GR73567B (ko)
HU (3) HU184712B (ko)
IE (1) IE49500B1 (ko)
IL (1) IL59189A (ko)
IN (1) IN153300B (ko)
IT (1) IT1149927B (ko)
LU (1) LU82105A1 (ko)
NL (1) NL8000385A (ko)
NO (2) NO151895C (ko)
NZ (3) NZ197582A (ko)
PH (4) PH15736A (ko)
PL (4) PL120774B1 (ko)
PT (1) PT70724A (ko)
SE (3) SE441358B (ko)
SU (3) SU1168094A3 (ko)
YU (2) YU269379A (ko)
ZA (1) ZA796374B (ko)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4432978A (en) * 1979-07-30 1984-02-21 Pfizer Inc. Hexahydro-trans-pyridoindole
US4431646A (en) * 1979-07-30 1984-02-14 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4431649A (en) * 1979-07-30 1984-02-14 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4337250A (en) * 1979-07-30 1982-06-29 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4427679A (en) 1981-01-16 1984-01-24 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4477669A (en) * 1982-09-30 1984-10-16 Pfizer Inc. Processes and intermediates useful in the preparation of flutroline
US4467090A (en) * 1982-09-30 1984-08-21 Pfizer Inc. Compound, 8-fluoro-5-(p-fluorophenyl)-2-[4-(p-fluorophenyl)-4-hydroxybutyryl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole
US4451655A (en) * 1982-05-17 1984-05-29 Pfizer Inc. Process for preparing carboline derivatives and compounds used in their preparation
US4568748A (en) * 1982-09-30 1986-02-04 Pfizer Inc. 2-Carbobenzoxy-8-fluoro-5-(p-fluorophenyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole
US4698444A (en) * 1982-09-30 1987-10-06 Pfizer Inc. 1,1-bis(p-fluorophenyl)urea
JPS61248502A (ja) * 1985-04-26 1986-11-05 Pioneer Electronic Corp 磁性材料の接合方法
US4672117A (en) * 1985-09-16 1987-06-09 American Home Products Corporation Antipsychotic gamma-carbolines
US4636563A (en) * 1985-09-16 1987-01-13 American Home Products Corporation Antipsychotic γ-carbolines
US4798896A (en) * 1988-01-19 1989-01-17 American Home Products Corporation Antipsychotic gamma-carboline N-oxides
US5075315A (en) * 1990-05-17 1991-12-24 Mcneilab, Inc. Antipsychotic hexahydro-2H-indeno[1,2-c]pyridine derivatives
ID28967A (id) * 1998-12-21 2001-07-19 Janssen Pharmaceutica Nv Benzisoksazol dan fenon sebagai alfa 2-antagonis
RU2329044C1 (ru) * 2006-11-16 2008-07-20 Андрей Александрович Иващенко Лиганды 5-ht6 рецепторов, фармацевтическая композиция, способ ее получения и лекарственное средство

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA551241A (en) * 1958-01-07 S. Abbott Leslie Production of substituted piperidines
US3382250A (en) * 1966-12-07 1968-05-07 Abbott Lab Aroylalkyl derivatives of 1, 2, 3, 4-tetrahydro-5h-pyrido[4, 3b]indoles
US3687961A (en) * 1971-05-03 1972-08-29 Abbott Lab 8-fluoro-2-{8 3-(4-fluorophenylanilinopropyl{9 -gamma-carboline
AR205452A1 (es) * 1973-12-06 1976-05-07 Endo Lab Metodo para preparar nuevos trans-2, 3, 4, 4a, 5, 9b-hexahidro-5-fenil-1h-pirido(4,3-b) indoles
JPS50126699A (ko) * 1974-03-20 1975-10-04
AR206812A1 (es) * 1974-04-01 1976-08-23 Pfizer Compuestos intermediarios de azaciclo(3,4-a)indoles 4- y 5-fenil substituidos desprovistos de actividad terapeutica
US4001263A (en) * 1974-04-01 1977-01-04 Pfizer Inc. 5-Aryl-1,2,3,4-tetrahydro-γ-carbolines
SE7702301L (sv) * 1976-04-08 1977-10-09 Endo Lab Trans-hexahydro-pyrido-indoler
SE441448B (sv) * 1977-05-23 1985-10-07 Pfizer Sett att framstella hexahydro-gamma-karbolinforeningar

Also Published As

Publication number Publication date
SE8404555L (sv) 1984-09-11
SE8404555D0 (sv) 1984-09-11
SE441358B (sv) 1985-09-30
DD149071A5 (de) 1981-06-24
ATA33380A (de) 1984-05-15
NZ197582A (en) 1984-05-31
BE881283A (fr) 1980-07-22
IL59189A0 (en) 1980-05-30
SU1168094A3 (ru) 1985-07-15
SE8404554L (sv) 1984-09-11
AU5476580A (en) 1980-07-31
AU521986B2 (en) 1982-05-13
CS221806B2 (en) 1983-04-29
LU82105A1 (fr) 1980-08-08
SE8404554D0 (sv) 1984-09-11
CS221807B2 (en) 1983-04-29
NO794317L (no) 1980-07-24
PL126867B1 (en) 1983-09-30
IT1149927B (it) 1986-12-10
NZ192175A (en) 1984-05-31
NO843041L (no) 1980-07-24
JPS5636486A (en) 1981-04-09
IL59189A (en) 1984-01-31
JPS5636487A (en) 1981-04-09
YU242183A (en) 1984-06-30
JPS5636475A (en) 1981-04-09
PT70724A (en) 1980-02-01
CS221809B2 (en) 1983-04-29
EG14767A (en) 1985-12-31
ZA796374B (en) 1980-11-26
FI800179A (fi) 1980-07-24
IT8019373A0 (it) 1980-01-22
PH17773A (en) 1984-12-11
PL126532B1 (en) 1983-08-31
FR2447379B1 (ko) 1983-08-19
FR2453174A1 (fr) 1980-10-31
CH651040A5 (fr) 1985-08-30
CA1144168A (en) 1983-04-05
PL120774B1 (en) 1982-03-31
SU1333239A3 (ru) 1987-08-23
JPS5855151B2 (ja) 1983-12-08
GR73567B (ko) 1984-03-16
GB2041925B (en) 1982-10-20
SU1080746A3 (ru) 1984-03-15
CH648314A5 (fr) 1985-03-15
PH15736A (en) 1983-03-18
YU269379A (en) 1984-04-30
CS221808B2 (en) 1983-04-29
JPS5740151B2 (ko) 1982-08-25
DK25580A (da) 1980-07-24
JPS55100386A (en) 1980-07-31
NZ197581A (en) 1984-05-31
IE800121L (en) 1980-07-23
HU189174B (en) 1986-06-30
FR2447379A1 (fr) 1980-08-22
NO151895B (no) 1985-03-18
PL126032B1 (en) 1983-07-30
HU184712B (en) 1984-10-29
SE8000329L (sv) 1980-07-24
PH15072A (en) 1982-06-03
DD156369A5 (de) 1982-08-18
GB2041925A (en) 1980-09-17
PL221248A1 (ko) 1980-12-01
NL8000385A (nl) 1980-07-25
FR2453174B1 (ko) 1983-07-29
DE3002367A1 (de) 1980-07-24
IN153300B (ko) 1984-06-30
AR231291A1 (es) 1984-10-31
HU188201B (en) 1986-03-28
AT376674B (de) 1984-12-27
KR830001932A (ko) 1983-05-19
IE49500B1 (en) 1985-10-16
FR2453175A1 (fr) 1980-10-31
PH15086A (en) 1982-07-02
US4224329A (en) 1980-09-23
FR2453175B1 (ko) 1983-07-29

Similar Documents

Publication Publication Date Title
NO790358L (no) Fremgangsmaate for fremstilling av alkylendiaminderivater
NO811731L (no) Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater
NO813678L (no) Fremgangsmaate for fremstilling av karbostyrilderivater
ES494635A0 (es) Procedimiento de preparacion de derivados de tiadiazol
NO792404L (no) Fremgangsmaate for fremstilling av imidazolderivater
NO794317L (no) Fremgangsmaate for fremstilling av pyrido-indolderivater
NO821848L (no) Fremgangsmaate for fremstilling av gamma-pyron-derivater
AR222691A1 (es) Procedimiento de preparacion de derivados hidroxi-de 2-isopropilamino-pirimidina
NO150799C (no) Fremgangsmaate for fremstilling av lysergol-derivater
SE7803035L (sv) Forfarande for framstellning av tienopyridinderivat
NO784382L (no) Fremgangsmaate for fremstilling av tiazoldin-derivater
NO813477L (no) Fremgangsmaate for fremstilling av karbostyrilderivater
NO801982L (no) Fremgangsmaate ved fremstilling av svovelholdige isokinolinderivater
NO802435L (no) Fremgangsmaate til fremstilling av tetrahydrokinolinderivater
NO793103L (no) Fremgangsmaate til fremstilling av cefalosporinderivater
NO152254C (no) Fremgangsmaate til fremstilling av karbazolderivater
NO780389L (no) Fremgangsmaate for fremstilling av erytromycin-derivater
NO792659L (no) Fremgangsmaate for fremstilling av karbostyrilderivater
NO812842L (no) Fremgangsmaate for fremstilling av aminoacetonitil-derivater
NO803115L (no) Fremgangsmaate for fremstilling av stivelselim
NO801234L (no) Fremgangsmaate for fremstilling av isopropylaminopyrimidin-hydroksyderivater
NO801724L (no) Fremgangsmaate for fremstilling av ergopeptin-derivater
NO800564L (no) Fremgangsmaate for fremstilling av penicillinderivater
SE436496B (sv) Forfarande for framstellning av dibensotiofenderivat
SE7700572L (sv) Forfarande for framstellning av tienopyridinderivat